Longitudinal population study with about 800 people in Gothenburg, Sweden. Part of the study is a one-hour cognitive test protocol which is being conducted since 2019 with Delta Clinical. Some 400 patients have already been included.
Validation ki:e SB-C
We are grateful to announce that we will soon be collaborating in a major new decentralized trial, funded by the Alzheimer Drug Discoveries Foundation (ADDF)